ecopipam has been researched along with sk&f 81297 in 2 studies
| Studies (ecopipam) | Trials (ecopipam) | Recent Studies (post-2010) (ecopipam) | Studies (sk&f 81297) | Trials (sk&f 81297) | Recent Studies (post-2010) (sk&f 81297) |
|---|---|---|---|---|---|
| 147 | 18 | 34 | 274 | 0 | 82 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vanover, KE; Weed, MR; Woolverton, WL | 1 |
| Bergman, J; Rosenzweig-Lipson, S | 1 |
2 other study(ies) available for ecopipam and sk&f 81297
| Article | Year |
|---|---|
Reinforcing effect of the D1 dopamine agonist SKF 81297 in rhesus monkeys.
Topics: Animals; Benzazepines; Cocaine; Conditioning, Operant; Dose-Response Relationship, Drug; Macaca mulatta; Receptors, Dopamine D1; Reinforcement, Psychology; Self Administration; Synaptic Transmission | 1993 |
Catalepsy-associated behavior induced by dopamine D1 receptor antagonists and partial dopamine D1 receptor agonists in squirrel monkeys.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antipsychotic Agents; Behavior, Animal; Benzazepines; Catalepsy; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Haloperidol; Isoquinolines; Male; Receptors, Dopamine D1; Saimiri; Tetrahydroisoquinolines | 1994 |